Apyx Medical CorporationAPYXNASDAQ
Loading
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Revenue | 49 | 45 | 52 |
| Gross Profit | 34 | 29 | 34 |
| Operating Income | -14 | -24 | -17 |
| Net Income | -15 | -23 | -19 |
| EBITDA | -14 | -22 | -18 |
| EPS Diluted | -0.44 | -0.67 | -0.54 |
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Cash & Equivalents | 31 | 10 | 44 |
| Total Current Assets | 61 | 43 | 70 |
| Total Assets | 69 | 52 | 79 |
| Total Current Liabilities | 13 | 12 | 13 |
| Total Liabilities | 15 | 14 | 52 |
| Total Equity | 54 | 38 | 27 |
| Total Debt | 0 | 1 | 39 |
| Net Debt | -31 | -9 | -5 |
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Operating Cash Flow | -10 | -20 | -5 |
| Capital Expenditure | -1 | -1 | -1 |
| Free Cash Flow | -11 | -21 | -6 |
| Stock-Based Comp | 5 | 7 | 5 |
| Net Change in Cash | -11 | -21 | 33 |